Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? - Yahoo Finance4 weeks ago • Google News
Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' - Seeking Alpha2025-02-19 • Google News
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Up 33.3% in April - Defense World2 weeks ago • Google News